Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
News about CVS Health Corporation (NYSE: CVS) covers developments across its roles in retail pharmacy, pharmacy benefit management, health insurance and health care delivery. Company press releases and related disclosures highlight how CVS Health communicates financial performance, strategic priorities, governance updates and community initiatives to investors, customers and the public.
Investors following CVS stock can find news on quarterly and full-year earnings announcements, financial guidance updates and Investor Day presentations. For example, CVS Health has issued press releases discussing results for specific quarters, updating full-year financial guidance and providing outlooks for future years, including projections for revenues, operating income, adjusted operating income, GAAP diluted earnings (loss) per share and adjusted EPS. These communications often appear in conjunction with Form 8-K filings that furnish the underlying press releases.
Corporate governance and leadership changes are another recurring news theme. CVS Health has announced Board decisions such as appointing its President and Chief Executive Officer, J. David Joyner, to the additional role of Chair of the Board, and it has used both press releases and Form 8-K filings to describe these actions and related Board structures.
Operational and community-focused news items describe how CVS Health engages with public health and local organizations. Examples include offering the measles-mumps-rubella (MMR) vaccine at select CVS Pharmacy and MinuteClinic locations in South Carolina during a measles outbreak, and the CVS Health Foundation’s grants to the American Diabetes Association to expand a maternal diabetes program in New York City. Other stories highlight investments in affordable housing projects and the company’s reported economic impact across U.S. states.
Visitors to this news page can review these types of announcements to understand how CVS Health presents its strategy, financial outlook, health services, community partnerships and responses to health challenges over time.
CVS Health (NYSE: CVS) has launched a new Clinical Trial Services business aimed at improving access to clinical trials, a sector where traditional enrollment has been low. The initiative addresses challenges such as participant engagement and retention, exacerbated by the COVID-19 pandemic. Key capabilities include precision patient recruitment, innovative clinical trial delivery, and real-world evidence generation. This move builds on CVS's previous experience with COVID-19 vaccine trials, where over 300,000 volunteers were engaged. The initiative aims to enhance efficiency and participant experience.
CVS Health has appointed Shawn Guertin as the new Chief Financial Officer, effective May 28, 2021. Guertin, previously with Aetna, brings extensive experience in financial strategies and healthcare transformation. He succeeds Eva Boratto, who served successfully for 11 years. CVS Health reaffirms its full-year 2021 guidance, with an Adjusted EPS forecast of $7.56 to $7.68 and cash flow from operations projected at $12.0 to $12.5 billion. The company aims to achieve a low 3x leverage ratio by 2022, emphasizing growth and stability.
CVS Health announced that COVID-19 vaccine appointments for adolescents aged 12 to 15 are now available at over 5,600 CVS Pharmacy locations nationwide, following FDA Emergency Use Authorization for the Pfizer-BioNTech vaccine. Starting May 13, 2021, eligible adolescents can receive the vaccine with parental consent. CVS has administered over 17 million vaccines and plans to offer services at over 9,600 locations by May 16, 2021. The company's Return Ready program will also provide on-site vaccination clinics for larger organizations.
CVS Pharmacy announces an upgrade to its CarePass membership, now offering free same-day prescription delivery for eligible members through a partnership with Shipt. This enhancement allows members to receive prescriptions within hours and adds access to everyday wellness essentials. CarePass members also benefit from a 24/7 pharmacist helpline, discounts on CVS Health products, and a monthly $10 Promo Reward. The program launched nationally in August 2019 and costs $5 per month or $48 annually. Same-day delivery is available at nearly 8,000 CVS stores across 47 states.
CVS Health announced it will begin administering COVID-19 vaccines at 19 select CVS Pharmacy locations in New Hampshire starting May 9, 2021. The vaccine will be available at no cost for patients with insurance and those uninsured through a federal program. Patients can utilize walk-in appointments or schedule same-day appointments via CVS.com. This initiative is part of the Federal Retail Pharmacy Program, which enables CVS to vaccinate communities across 50 states and other territories, ensuring over 70% of the U.S. population is within 5 miles of a CVS location.
CVS Health reported a strong performance for Q1 2021, with total revenues of $69.1 billion, a 3.5% increase year-over-year. The company achieved a GAAP diluted EPS of $1.68, up 9.8% from last year. Adjusted EPS also rose to $2.04, reflecting a 6.8% growth. The firm raised its full-year GAAP diluted EPS guidance to $6.24-$6.36 and Adjusted EPS to $7.56-$7.68. Notably, cash flow from operations reached $2.9 billion. CEO Karen S. Lynch emphasized the company's commitment to enhancing care delivery amidst ongoing recovery from the pandemic.
CVS Health has launched initiatives to enhance women's health during May, providing no-cost heart health screenings at MinuteClinic locations from May 9 to May 15. This effort aims to address the significant risk of heart disease among women. Additionally, CVS Pharmacy is offering discounts on women's wellness products through May 22. The company is also supporting the American Heart Association's Go Red for Women movement, raising nearly $20 million since 2017. These initiatives underline CVS Health's commitment to personalized women's health care.
CVS Health has announced the expansion of its no-cost community screening program, Project Health, into 14 new metro markets. This initiative aims to provide crucial health screenings to underserved populations, marking the program's 16th year. CVS will host over 1,700 events across 32 metro areas by December. The expansion follows a $600 million commitment to tackle inequality affecting marginalized communities. Project Health has offered more than $134 million in healthcare services since 2006, focusing on preventive care for chronic conditions.
CVS Health has launched CVS Health Ventures, a corporate venture capital fund with an initial allocation of $100 million. The fund aims to invest in early-stage companies focused on enhancing accessibility and affordability in healthcare. CVS Health has previously made over 20 direct investments, yielding strong returns. The initiative aims to foster partnerships and accelerate innovation in digital healthcare, aligning with CVS's goal to provide better health experiences for consumers.
Summary not available.